Shares turn range bound

Image
Capital Market
Last Updated : Jul 12 2019 | 1:50 PM IST

Key barometers continued trading in a range in early afternoon trade. At 12:23 IST, the barometer index, the S&P BSE Sensex, was down 3.24 points or 0.01% at 38,819.47. The Nifty 50 index was down 1.25 points or 0.01% at 11,581.65.

The S&P BSE Mid-Cap index was up 0.5%. The S&P BSE Small-Cap index was up 0.37%. Both these indices outperformed the Sensex.

The market breadth, indicating the overall health of the market, was positive. On the BSE, 1069 shares rose and 1027 shares fell. A total of 118 shares were unchanged.

Metal stocks advanced. Jindal Steel & Power (up 3.58%), Tata Steel (up 2.25%), Vedanta (up 1.92%), NMDC (up 1.77%), National Aluminium Company (up 1.5%), Steel Authority of India (up 1.39%), Hindalco Industries (up 0.71%), Hindustan Zinc (up 0.2%) and Hindustan Copper (up 0.01%) gained.

Power Finance Corporation was up 0.04% to Rs 126.25. Reports suggested that company's 6.3 crore shares, or 2.4% equity, changed hands in two block deals on NSE at an average price of Rs 125 per share.

ACC was up 1.5% to Rs 1574.05 after a foreign brokerage upgraded ACC to neutral from underperform rating and raised price target to Rs 1,695 from Rs 1,586.

Ambuja Cements was up 1.49% to Rs 214.7 after a foreign brokerage house upgraded Ambuja Cements to buy from neutral and raised price target to Rs 261 from Rs 238.

PVR was up 1.62% to Rs 1757.45 after multiplex cinema company announced that it has opened 9-screen multiplex in Gaur City Mall, Greater Noida. This will be PVR's second multiplex in Greater Noida. With this launch, PVR now operates the largest multiplex network with of 794 screens at 168 properties in 67 cities.

Most pharma stocks gained. Sun Pharmaceuticals Industries (up 2.57%), Piramal Enterprises (up 0.99%), Lupin (up 0.88%), Wockhardt (up 0.8%), Cadila Healthcare (up 0.64%), Glenmark Pharmaceuticals (up 0.54%), Alkem Laboratories (up 0.4%), Cipla (up 0.39%) and GlaxoSmithKline Pharmaceuticals (up 0.02%) edged higher. Divi's Laboratories (down 0.71%), Dr Reddy's Laboratories (down 0.57%), Aurobindo Pharma (down 0.29%) and IPCA Laboratories (down 0.11%) declined.

Meanwhile, the monsoon has made a great start in July. Average countrywide rainfall in the first 11 days of the month has been 24% above normal, which has helped reduce the overall monsoon deficit to almost a third, from 33% at the end of June to 12%.

On derivatives front, the NSE's India VIX, a gauge of market's expectation of volatility over the near term, fell 2.14% at 12.2025

On the options front, Nifty option chain for 25 July 2019 expiry showed a maximum call open interest (OI) of 31.33 lakh contracts at the 12000 strike price. Maximum put OI of 21.78 lakh contracts was seen at 11300 strike price. Options data suggested a trading range for Nifty will be between 11,300 and 12,000.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 12 2019 | 12:22 PM IST

Next Story